The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Lewis Tanya since 2020.
This trader's CIK number is 1451038.
At the time of last reporting, Lewis Tanya was the Chief Dev. Op. Officer of Replimune Group, Inc.. (stock ticker symbol REPL).
Also see all insider trading activities at Replimune Group, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | KPTI | 0 | $0 | 2,046 | $31,751 | 5,650 | $0 |
| 2020 | KPTI | 0 | $0 | 226 | $3,521 | 765 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | REPL | 0 | $0 | 25,067 | $526,082 | 0 | $0 |
| 2022 | REPL | 0 | $0 | 5,473 | $79,851 | 0 | $0 |
1. Karyopharm Therapeutics Inc. (KPTI)
2. Replimune Group, Inc. (REPL)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-02-11 | KPTI | Sale | 2,046 | 15.52 | 31,751 |
| 2021-02-05 | KPTI | Option Ex | 5,650 | .00 | 0 |
| 2020-10-30 | KPTI | Sale | 226 | 15.58 | 3,521 |
| 2020-10-28 | KPTI | Option Ex | 765 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-06-13 | REPL | Sale | 12,860 | 23.77 | 305,746 |
| 2023-05-16 | REPL | Sale | 12,207 | 18.05 | 220,336 |
| 2022-05-16 | REPL | Sale | 5,473 | 14.59 | 79,851 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lewis Tanya (Chief Dev. Op. Officer of Replimune Group, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.